Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

NCT00139581 ·Status: COMPLETED ·Phase: PHASE4

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

NCT00120523 ·Status: COMPLETED ·Phase: PHASE3

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

NCT00351052 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

NCT00121316 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

NCT00510003 ·Status: COMPLETED ·Phase: PHASE4

Immune Response to Varicella Vaccination in Children With Atopic Dermatitis

NCT00406081 ·Status: COMPLETED

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

NCT02103725 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

NCT00150059 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

NCT00226707 ·Status: COMPLETED ·Phase: PHASE3

Effects of Treatments on Atopic Dermatitis

NCT01631617 ·Status: RECRUITING ·Phase: PHASE2

Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

NCT00232115 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

NCT02748993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

NCT00925730 ·Status: COMPLETED ·Phase: PHASE4

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

NCT00407069 ·Status: COMPLETED

Pimecrolimus and Epidermal Barrier Function

NCT01132079 ·Status: COMPLETED ·Phase: NA

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

NCT00568997 ·Status: ACTIVE_NOT_RECRUITING

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

NCT04900948 ·Status: COMPLETED ·Phase: PHASE4

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

NCT00232011 ·Status: COMPLETED ·Phase: PHASE3

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

NCT00231998 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

NCT02118792 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

NCT02757729 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

NCT06807268 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

NCT02118766 ·Status: COMPLETED ·Phase: PHASE3

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

NCT00484003 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

NCT01756898 ·Status: COMPLETED ·Phase: PHASE2